RGD Reference Report - Exome Sequencing Reveals AMER1 as a Frequently Mutated Gene in Colorectal Cancer. - Rat Genome Database

Send us a Message



Submit Data |  Help |  Video Tutorials |  News |  Publications |  Download |  REST API |  Citing RGD |  Contact   

Exome Sequencing Reveals AMER1 as a Frequently Mutated Gene in Colorectal Cancer.

Authors: Sanz-Pamplona, R  Lopez-Doriga, A  Pare-Brunet, L  Lazaro, K  Bellido, F  Alonso, MH  Ausso, S  Guino, E  Beltran, S  Castro-Giner, F  Gut, M  Sanjuan, X  Closa, A  Cordero, D  Moron-Duran, FD  Soriano, A  Salazar, R  Valle, L  Moreno, V 
Citation: Sanz-Pamplona R, etal., Clin Cancer Res. 2015 Oct 15;21(20):4709-18. doi: 10.1158/1078-0432.CCR-15-0159. Epub 2015 Jun 12.
RGD ID: 11527838
Pubmed: PMID:26071483   (View Abstract at PubMed)
PMCID: PMC4609254   (View Article at PubMed Central)
DOI: DOI:10.1158/1078-0432.CCR-15-0159   (Journal Full-text)

PURPOSE: Somatic mutations occur at early stages of adenoma and accumulate throughout colorectal cancer progression. The aim of this study was to characterize the mutational landscape of stage II tumors and to search for novel recurrent mutations likely implicated in colorectal cancer tumorigenesis. EXPERIMENTAL DESIGN: The exomic DNA of 42 stage II, microsatellite-stable colon tumors and their paired mucosae were sequenced. Other molecular data available in the discovery dataset [gene expression, methylation, and copy number variations (CNV)] were used to further characterize these tumors. Additional datasets comprising 553 colorectal cancer samples were used to validate the discovered mutations. RESULTS: As a result, 4,886 somatic single-nucleotide variants (SNV) were found. Almost all SNVs were private changes, with few mutations shared by more than one tumor, thus revealing tumor-specific mutational landscapes. Nevertheless, these diverse mutations converged into common cellular pathways, such as cell cycle or apoptosis. Among this mutational heterogeneity, variants resulting in early stop codons in the AMER1 (also known as FAM123B or WTX) gene emerged as recurrent mutations in colorectal cancer. Losses of AMER1 by other mechanisms apart from mutations such as methylation and copy number aberrations were also found. Tumors lacking this tumor suppressor gene exhibited a mesenchymal phenotype characterized by inhibition of the canonical Wnt pathway. CONCLUSIONS: In silico and experimental validation in independent datasets confirmed the existence of functional mutations in AMER1 in approximately 10% of analyzed colorectal cancer tumors. Moreover, these tumors exhibited a characteristic phenotype.

RGD Manual Disease Annotations    Click to see Annotation Detail View
TermQualifierEvidenceWithReferenceNotesSourceOriginal Reference(s)
colorectal cancer  IAGP 11527838DNA:SNPs:multiple (human)RGD 
colorectal cancer  ISOAMER1 (Homo sapiens)11527838; 11527838DNA:SNPs:multiple (human)RGD 

Phenotype Annotations    Click to see Annotation Detail View

Manual Human Phenotype Annotations - RGD

TermQualifierEvidenceWithReferenceNotesSourceOriginal Reference(s)
Neoplasm of the large intestine  IAGP 11527838DNA:SNPs:multiple RGD 
Objects Annotated

Genes (Rattus norvegicus)
Amer1  (APC membrane recruitment protein 1)

Genes (Mus musculus)
Amer1  (APC membrane recruitment 1)

Genes (Homo sapiens)
AMER1  (APC membrane recruitment protein 1)


Additional Information